SCHEMBL19655111

SCHEMBL19655111

c1ccc2c(-c3nc4c5ccccc5c5ccccc5c4nc3-n3c4ccccc4c4c5c6ccccc6n(-c6nc7c8ccccc8c8ccccc8c7nc6-c6cccc7ccccc67)c5ccc43)cccc2c1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.35
MAPT P10636 1/20 0.35
HPGD P15428 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
TUBB4A P04350 1/20 0.33
TUBB P07437 1/20 0.33
TUBA3C P0DPH7 1/20 0.33
TUBA1B P68363 1/20 0.33
TUBA4A P68366 1/20 0.33
TUBB4B P68371 1/20 0.33
TUBB3 Q13509 1/20 0.33
TUBB2A Q13885 1/20 0.33
TUBB8 Q3ZCM7 1/20 0.33
TUBA3E Q6PEY2 1/20 0.33
TUBA1A Q71U36 1/20 0.33
TUBA1C Q9BQE3 1/20 0.33
TUBB6 Q9BUF5 1/20 0.33
TUBB2B Q9BVA1 1/20 0.33
TUBB1 Q9H4B7 1/20 0.33
KDM4E B2RXH2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19653784 0.94 KDM4E (0.40) ALDH1A1MAPTHPGDSMN1; SMN2TUBB4A
SCHEMBL19655157 0.86 TUBB4A (0.38) ALDH1A1MAPTHPGDSMN1; SMN2TUBB4A
SCHEMBL19655103 0.85 CYP1A2 (0.39) ALDH1A1MAPTHPGDSMN1; SMN2TUBB4A
SCHEMBL19655131 0.84 DUSP3 (0.38) ALDH1A1MAPTHPGDSMN1; SMN2TUBB4A
SCHEMBL19655105 0.82 PTGER1 (0.35) ALDH1A1MAPTHPGDSMN1; SMN2KDM4E
SCHEMBL19653823 0.81 GSR (0.36) ALDH1A1MAPTHPGDKDM4ECNR1
SCHEMBL19655342 0.81 KDM4E (0.43) ALDH1A1MAPTHPGDSMN1; SMN2TUBB4A
SCHEMBL24104095 0.80 GSR (0.39) ALDH1A1MAPTHPGDSMN1; SMN2TUBB4A
SCHEMBL19653890 0.80 KDM4E (0.41) ALDH1A1MAPTHPGDSMN1; SMN2KDM4E
SCHEMBL19655107 0.79 TUBB4A (0.38) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10840458-B2 Organic electroluminescent materials and devices UNIVERSAL DISPLAY CORPORATION (US) 2020-11-17 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2017-11-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170346022-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES PDXK, MT-ND4L, PNPO ALDH1A1 2673/4885MAPT 2438/4885HPGD 592/4885
US-10840458-B2 Organic electroluminescent materials and devices PDXK, MT-ND4L, PNPO ALDH1A1 2673/4885MAPT 2438/4885HPGD 592/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.